Significance and management of micrometastases in patients with breast cancer

References

• Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg.220(3), 391–398 (1994).
   PubMed Web of Science ®Google Scholar
• Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA276(22), 1818–1822 (1996).
   PubMed Web of Science ®Google Scholar
• Giuliano AE. Lymphatic mapping and sentinel node biopsy in breast cancer. JAMA277(10), 791–792 (1997).
   PubMedGoogle Scholar
• Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med.349(6), 546–553 (2003).
   PubMed Web of Science ®Google Scholar
• Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J. Surg. Oncol.62(2), 75–77 (1996).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet349(9069), 1864–1867 (1997).
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J. Clin. Oncol.20(17), 3628–3636 (2002).
   PubMed Web of Science ®Google Scholar
• Breast. In: American Joint Committee on Cancer Cancer Staging Manual (6th Edition). Greene FL, Page DL, Fleming ID (Eds). Springer, NY, USA 223–240 (2002).
   Google Scholar
• Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer98(12), 2740–2741 (2003).
   PubMed Web of Science ®Google Scholar
• Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J. Clin.56(1), 37–47 (2006).
   PubMed Web of Science ®Google Scholar
• Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet335(8705), 1565–1568 (1990).
   PubMed Web of Science ®Google Scholar
• Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet354(9182), 896–900 (1999).
   PubMed Web of Science ®Google Scholar
• de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br. J. Cancer66(3), 523–527 (1992).
   PubMed Web of Science ®Google Scholar
• Noguchi S, Aihara T, Nakamori S et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer74(5), 1595–1600 (1994).
   PubMed Web of Science ®Google Scholar
• Sedmak DD, Meineke TA, Knechtges DS, Anderson J. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod. Pathol.2(5), 516–520 (1989).
   PubMed Web of Science ®Google Scholar
• Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br. J. Cancer55(3), 303–306 (1987).
   PubMed Web of Science ®Google Scholar
• Boughey JC, Bedrosian I, Meric-Bernstam F et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J. Am. Coll. Surg.203(4), 475–480 (2006).
   PubMed Web of Science ®Google Scholar
• Cox C, White L, Allred N et al. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann. Surg. Oncol.13(5), 708–711 (2006).
   PubMed Web of Science ®Google Scholar
• Weaver DL, Krag DN, Ashikaga T, Harlow SP, O’Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer88(5), 1099–1107 (2000).
   PubMed Web of Science ®Google Scholar
• Weaver DL, Krag DN, Manna EA et al. Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study. Cancer107(4), 661–667 (2006).
   PubMed Web of Science ®Google Scholar
• Fitzgibbons PL, Page DL, Weaver D et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med.124(7), 966–978 (2000).
   PubMed Web of Science ®Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol.23(30), 7703–7720 (2005).
   PubMed Web of Science ®Google Scholar
• Viale G, Bosari S, Mazzarol G et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer85(11), 2433–2438 (1999).
   PubMed Web of Science ®Google Scholar
• Viale G, Maiorano E, Mazzarol G et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer92(6), 1378–1384 (2001).
   PubMed Web of Science ®Google Scholar
• Yared MA, Middleton LP, Smith TL et al. Recommendations for sentinel lymph node processing in breast cancer. Am. J. Surg. Pathol.26(3), 377–382 (2002).
   PubMed Web of Science ®Google Scholar
• Cserni G, Bianchi S, Boecker W et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer103, 358–367 (2005).
   PubMed Web of Science ®Google Scholar
• Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. The Ludwig Breast Cancer Study Group. N. Engl. J. Med.320(8), 491–496 (1989).
   PubMed Web of Science ®Google Scholar
• Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer J. Clin.47(1), 28–51 (1997).
   PubMed Web of Science ®Google Scholar
• Fisher B, Bauer M, Wickerham DL et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer52(9), 1551–1557 (1983).
   PubMed Web of Science ®Google Scholar
• Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer42(4), 2025–2031 (1978).
   PubMed Web of Science ®Google Scholar
• Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann. Surg.173(1), 44–46 (1971).
   PubMed Web of Science ®Google Scholar
• Pickren JW. Significance of occult metastases. A study of breast cancer. Cancer14, 1266–1271 (1961).
   PubMed Web of Science ®Google Scholar
• Maibenco DC, Dombi GW, Kau TY, Severson RK. Significance of micrometastases on the survival of women with T1 breast cancer. Cancer107(6), 1234–1239 (2006).
   PubMed Web of Science ®Google Scholar
• Friedman S, Bertin F, Mouriesse H et al. Importance of tumor cells in axillary node sinus margins (‘clandestine’ metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol.27(5), 483–487 (1988).
   PubMed Web of Science ®Google Scholar
• Hainsworth PJ, Tjandra JJ, Stillwell RG et al. Detection and significance of occult metastases in node-negative breast cancer. Br. J. Surg.80(4), 459–463 (1993).
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br. J. Cancer73(1), 88–95 (1996).
   PubMed Web of Science ®Google Scholar
• Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in “node-negative” breast carcinoma. Hum. Pathol.24(9), 950–957 (1993).
   PubMed Web of Science ®Google Scholar
• Wilkinson EJ, Hause LL, Hoffman RG et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol. Annu.17(Pt 2), 67–91 (1982).
   PubMedGoogle Scholar
• Querzoli P, Pedriali M, Rinaldi R et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin. Cancer Res.12(22), 6696–6701 (2006).
   PubMed Web of Science ®Google Scholar
• Hansen NM, Grube BJ, Te W et al. Clinical significnace of axillary micrometastases in breast cancer: how small is too small? Proc. Am. Soc. Clin. Oncol.20, A91 (2001).
   Google Scholar
• Cox C, Vrcel V, Riker A et al. Significance of sentinel lymph node micrometastasis on survival for patients with invasive breast cancer. Breast Cancer Res. Treat.94, S12–S13 (2005).
   Google Scholar
• Chagpar A, Middleton LP, Sahin AA et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer103(8), 1581–1586 (2005).
   PubMed Web of Science ®Google Scholar
• Krag DN, Julian TB, Harlow SP et al. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann. Surg. Oncol.11(Suppl. 3), S208–S210, (2004).
   PubMed Web of Science ®Google Scholar
• Changsri C, Prakash S, Sandweiss L, Bose S. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J.10(5), 392–397 (2004).
   PubMedGoogle Scholar
• Giard S, Baranzelli MC, Robert D et al. Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer. Eur. J. Surg. Oncol.30(9), 924–929 (2004).
   PubMed Web of Science ®Google Scholar
• Hwang RF, Krishnamurthy S, Hunt KK et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann. Surg. Oncol.10(3), 248–254 (2003).
   PubMed Web of Science ®Google Scholar
• Liang WC, Sickle-Santanello BJ, Nims TA. Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am. J. Surg.182(4), 365–368 (2001).
   PubMed Web of Science ®Google Scholar
• McCready DR, Yong WS, Ng AK, Miller N, Done S, Youngson B. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J. Natl Cancer Inst.96(11), 873–875 (2004).
   PubMedGoogle Scholar
• Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J. Surg. Oncol.28(6), 623–626 (2002).
   PubMed Web of Science ®Google Scholar
• Nos C, Harding-MacKean C, Freneaux P et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br. J. Surg.90(11), 1354–1360 (2003).
   PubMed Web of Science ®Google Scholar
• Saidi RF, Dudrick PS, Remine SG, Mittal VK. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am. Surg.70(2), 101–105 (2004).
   PubMed Web of Science ®Google Scholar
• van Rijk MC, Peterse JL, Nieweg OE, Oldenburg HS, Rutgers EJ, Kroon BB. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer107(3), 467–471 (2006).
   PubMed Web of Science ®Google Scholar
• Weiser MR, Montgomery LL, Tan LK et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann. Surg. Oncol.8(2), 145–149 (2001).
   PubMed Web of Science ®Google Scholar
• Zavagno G, De Salvo GL, Bozza F et al. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res. Treat.86(2), 171–179 (2004).
   PubMed Web of Science ®Google Scholar
• Cserni G, Gregori D, Merletti F et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br. J. Surg.91(10), 1245–1252 (2004).
   PubMed Web of Science ®Google Scholar
• Viale G, Maiorano E, Pruneri G et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann. Surg.241(2), 319–325 (2005).
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Nos C, Mignotte H et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement – Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J. Clin. Oncol.24(12), 1814–1822 (2006).
   PubMed Web of Science ®Google Scholar
• Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann. Surg. Oncol.6(8), 756–761 (1999).
   PubMed Web of Science ®Google Scholar
• Czerniecki BJ, Scheff AM, Callans LS et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer85(5), 1098–1103 (1999).
   PubMed Web of Science ®Google Scholar
• Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J.10(2), 101–105 (2004).
   PubMedGoogle Scholar
• Reynolds C, Mick R, Donohue JH et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J. Clin. Oncol.17(6), 1720–1726 (1999).
   PubMed Web of Science ®Google Scholar
• Turner RR, Chu KU, Qi K et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer89(3), 574–581 (2000).
   PubMed Web of Science ®Google Scholar
• Kamath VJ, Giuliano R, Dauway EL et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch. Surg.136(6), 688–692 (2001).
   PubMedGoogle Scholar
• Recht A, Edge SB. Evidence-based indications for postmastectomy irradiation. Surg. Clin. North Am.83(4), 995–1013 (2003).
   PubMed Web of Science ®Google Scholar
• Recht A, Edge SB, Solin LJ et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol.19(5), 1539–1569 (2001).
   PubMed Web of Science ®Google Scholar
• Rivers AK, Griffith KA, Hunt KK et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann. Surg. Oncol.13(1), 36–44, (2006).
   PubMed Web of Science ®Google Scholar
• Louis-Sylvestre C, Clough K, Asselain B et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J. Clin. Oncol.22(1), 97–101 (2004).
   PubMed Web of Science ®Google Scholar
• Gadd M, Harris J, Taghian A et al. Prospective study of axillary radiation without axillary dissection for breast cancer patients with a positive sentinel node. Breast Cancer Res. Treat.94(Suppl.), S13 (2005).
   Google Scholar
• van de Vijver MJ, He YD, van’t Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med.347(25), 1999–2009 (2002).
   PubMed Web of Science ®Google Scholar